CHA AI Healthcare announced on the 24th that it had completed the payment for the purchase of existing shares in connection with its acquisition of a stake in Kakao Healthcare, which it undertook together with CHA Cares of CHA Bio Group on the 23rd, and that the transaction has been finalized.
The completion of this transaction is a follow-up procedure to the previously signed equity acquisition and strategic collaboration agreement. All payments for the purchase of existing shares, as stipulated in the contract, have been fulfilled, thereby finalizing the key terms of the transaction.
CHA AI Healthcare plans to foster the establishment and operation of medical IT infrastructure as a core growth driver, leveraging this transaction as an opportunity.
The two companies will collaborate based on their respective areas of expertise. CHA AI Healthcare will serve as the main entity for the establishment and operation of hospital IT infrastructure in the future. Kakao Healthcare will provide its AI and data-driven digital healthcare technology capabilities, aiming to advance business models within hospitals by implementing what is referred to as a 'Physical AI' foundation in the hospital operating environment.
In addition, CHA AI Healthcare plans to secure both profitability and sustainability in its medical IT business by moving beyond simple project-based infrastructure development to an integrated operational model that encompasses stable post-construction management, continuous system upgrades, and data utilization.
Yoon Kyungwook, CEO of CHA AI Healthcare, stated, "The completion of this transaction marks the transition of our medical IT infrastructure and AI-based business strategy into a full-scale implementation phase. Through this, we will foster business models within hospitals based on Physical AI, which directly implements AI into hospital operations and infrastructure, as a key growth axis."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
